摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

K(Priso) | 1119723-34-0

中文名称
——
中文别名
——
英文名称
K(Priso)
英文别名
potassium(N(2,6-iPr2C6H3))2C(N(iPr2));K((2,6-diisopropylphenyl)N)2CNiPr2)
K(Priso)化学式
CAS
1119723-34-0
化学式
C31H48N3*K
mdl
——
分子量
501.841
InChiKey
NHWHPBUWZMUCTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.0
  • 重原子数:
    35.0
  • 可旋转键数:
    8.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    29.7
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    K(Priso) 、 iron(II) bromide 以 四氢呋喃 为溶剂, 反应 36.0h, 以79%的产率得到
    参考文献:
    名称:
    Donor Properties of a New Class of Guanidinate Ligands Possessing Ketimine Backbones: A Comparative Study Using Iron
    摘要:
    Addition of 1 equiv of LiN=(CBu2)-Bu-t or LiN=Ad (Ad = 2-adamantyl) to the aryl carbodiimide C(NDipp)(2) (Dipp = 2,6-diisopropylphenyl) readily generates the lithium ketimine-guanidinates Li(THF)(2)[(X)C(NDipp)(2)] (X = N=(CBu2)-Bu-t (1-Bu-t), N=-Ad (1-Ad)) in excellent yields. These new ligands can be readily metalated with iron to give the N,N'-bidentate chelates [{(X)C(NDipp)(2)}-FeBr](2) (X = N=(CBu2)-Bu-t (5-Bu-t), N=Ad (5-Ad)), in which the ketimines behave as noncoordinating backbone subst:ituents. In an effort to understand the potential electronic contributions of the ketimine group to the ligand architecture, a thorough structural and electronic study was conducted comparing the features and properties of 5-Bu-t and 5-Ad to their guanidinate and amidinate analogues [I(X) C(NDipp)(2)}FeBr](2) (X = (Pr2N)-Pr-i (6), Bu-t (7)). Solid-state structural analyses indicate little electronic contribution from the N-ketimine nitrogen atom, while solution-phase electronic absorption spectra of 5-Bu-t and 5-Ad are qualitatively similar to the amidinate complex 7. Yet, electrochemical measurements do show the donor properties of the ketimineguanidinate in 5-Bu-t to be intermediate between its guanidinate and amidinate counterparts in 6 and 7. Preliminary reactivity studies also show that the reduction chemistry of 5-Bu-t diverges significantly from that of 6 and 7. Treatment of 5-Bu-t with excess magnesium or 1 equiv of KC8 leads to the formation of the Fe(I)-Fe(I) complex [mu-((Bu2C)-Bu-t=N)C(NDipp)(2)}(2)Fe-2] (11), which possesses an exceedingly short Fe=Fe bond (2.1516(5) angstrom), while neither 6 nor 7 forms dinuclear complexes upon reduction. This result demonstrates that ketitine-guanidinates do not simply behave as amidinate variants but can contribute to distinctive metal chemistry of their own.
    DOI:
    10.1021/acs.inorgchem.5b01815
  • 作为产物:
    描述:
    2,3-bis(2,6-diisopropylphenyl)-1,1-diisopropylguanidine 在 双(三甲基硅烷基)氨基钾 作用下, 以 甲苯 为溶剂, 反应 4.0h, 以86%的产率得到K(Priso)
    参考文献:
    名称:
    Synthesis and characterisation of bulky guanidines and phosphaguanidines: precursors for low oxidation state metallacycles
    摘要:
    碱金属酰胺或磷化物与大体积碳二亚胺 ArNCNAr(Ar = C6H3Pri2-2,6)反应,然后进行水性加 工,得到了几种胍类化合物 ArNC(NR2)N(H)Ar(R = 环己基 (GisoH) 或 Pri (PrisoH));NR2=顺式-NC5H8Me2-2,6(PipisoH))、一种双官能胍,{ArNCN(H)Ar}2{μ-N(C2H4)2N}(Pip(GisoH)2)和两种磷胍,ArNC(PR2)N(H)Ar(R=环己基(CyP-GisoH)或 Ph(PhP-GisoH))。我们还通过其他方法制备了一种非常笨重的胍类化合物 ArNC{N(Ar)SiMe3}N(H)Ar (ArSi-Giso),以及一种芳基偶联双官能胍类化合物 {ArN(H)C(NPri2)NC6H2Pri2-2,6-}2 (PrisoH)2。所有化合物都经过了晶体学表征,并显示在固态下存在多种异构体。这些异构体似乎在溶液中基本保持不变。GisoH 与 BunLi 在己烷或四氢呋喃中发生去质子化反应,分别生成了具有晶体学特征的二聚体和单体复合物,即 [Li{Li(κ2-N,N′-Giso)2}] 和 [Li(THF)(η1-N,η3-Ar-Giso)]。PrisoH 和 Pip(GisoH)2 与 K[N(SiMe3)2] 发生去质子化反应后,分别得到非溶解聚合物 [{K(η1-N,η6-Ar-Priso)}∞] 和溶解复合物 [{K(THF)2}{Pip(Giso)2}{K(THF)3}]。
    DOI:
    10.1039/b809120j
点击查看最新优质反应信息

文献信息

  • Low coordinate lanthanide(ii) complexes supported by bulky guanidinato and amidinato ligands
    作者:Dennis Heitmann、Cameron Jones、David P. Mills、Andreas Stasch
    DOI:10.1039/b924367d
    日期:——
    the closely related complex, [(κ2-N,N′-Priso)Yb(THF)(μ-I)}2], the ytterbium atoms are κ2-N,N′-chelated by the guanidinate ligand. The facility of the planar four-coordinate complex, [Sm(Giso)2], to act as a one-electron reducing agent towards a variety of unsaturated substrates has also been explored. The complex has been shown to selectively reductively couple CS2, via a C–S bond formation, to give
    编写一系列均四,四坐标 系元素(II)络合物[Ln(Priso)2 ](Ln =m, 欧盟 或者 b)合并笨重 胍盐配体Priso -([(ArN )2 CNPr i 2] -,气 = 2,6-二异丙基苯基)进行了说明。X射线晶体学显示该配合物是同构的,并且在四面体和平面之间的中间表现出配位几何形状。复合物的几何形状和与笨重的系统之间的比较,[LN(Giso)2 ](Giso - = [(ArN )2 CNCy 2] -,半胱酸=环己基)。尝试准备受阻较小的人mid 配合物,[Ln(皮索)2](皮索- = [(ARN)2 CBU吨] - ),没有成功,但确实引起的杂配体络合物,[(κ 1 -N,η 6 -Piso)的Sm(THF)(μ-I)2 SM(κ 1 -N,η 6 -Piso)]。而该络合物中的mid酰胺配体则螯合了中心在κ 1 -N,η 6 -Ar-方式,在密切相关的复杂的,[(κ
  • Amidinato- and Guanidinato-Cobalt(I) Complexes: Characterization of Exceptionally Short Co-Co Interactions
    作者:Cameron Jones、Christian Schulten、Richard P. Rose、Andreas Stasch、Simon Aldridge、William D. Woodul、Keith S. Murray、Boujemaa Moubaraki、Marcin Brynda、Giovanni La Macchia、Laura Gagliardi
    DOI:10.1002/anie.200900780
    日期:2009.9.21
    CoCo loco! Ligand‐bridged dimers (see picture) with the shortest known Co–Co interactions are the first amidinato and guanidinato cobalt(I) complexes. The nature of the interactions has been probed by magnetic and theoretical investigations, and has been shown to be multiconfigurational. Preliminary reactivity studies of the complexes have also been carried out.
    可可机车!已知Co-Co相互作用最短的配体桥联二聚体(见图)是第一个a基和(I)配合物。相互作用的性质已通过磁性和理论研究探究,并已证明是多构型的。配合物的初步反应性研究也已经进行。
  • Stabilisation of carbonyl free amidinato-manganese(<scp>ii</scp>) hydride complexes: “masked” sources of manganese(<scp>i</scp>) in organometallic synthesis
    作者:Lea Fohlmeister、Cameron Jones
    DOI:10.1039/c5dt04504e
    日期:——
    η3-arene-Piso)Mn(μ-H)2}2] and the isomorphous manganese(I) complex, [(N-,η3-arene-Piso)Mn}2], toward CO, O2 and N2O was carried out. Reactions with the manganese(I) and manganese(II) species gave identical results, namely the formation of the manganese(I) carbonyl complex, [(κ2-N,N′-Piso)Mn(CO)4] (reactions with CO), and the manganese(III)-μ-oxo complex, [(κ2-N,N′-Piso)Mn(μ-O)}2] (reactions with O2
    所述amidinato(的反应II),化络合物,[(κ 2 - Ñ,Ñ '-Piso)的Mn(μ-)} 3(THF)2 ](皮索= [(DIPN)2 CBU吨] -,DIP = 2,6-二异丙基)中,用K [BHET 3 ]得到的第一示例的结构认证amidinato(II)氢化物络合物,[(ñ - ,η 3 -arene-皮索)的Mn(μ- H)2 } 2 ],通过涉及改变ate酰胺配位模式的过程。处理体积较大的前体复合物[(Piso'')Mn(μ-Br)}n ](Piso''= [(Dip''N) 2 CBu t ] -,Dip''= C 6 H 2 Pr i 2(CPh 3)-2,6,4),用K [BHEt 3 ]做不会导致可分离的氢化锰配合物,但会与(I)配合物[( Mes Nacnac)Mg} 2 ]( Mes Nacnac = [(MesNCMe) 2 CH] -,Mes
  • Flexible coordination of bulky amidinates and guanidinates towards rhodium(i): conversion of kinetic to thermodymanic isomers
    作者:Cameron Jones、David P. Mills、Andreas Stasch
    DOI:10.1039/b806542j
    日期:——
    Reactions of the bulky amidinate and guanidinate salts K[(ArN)2CR] (R = But, NPri2 or N(C6H11)2; Ar = 2,6-diisopropylphenyl) with [RhCl(η4-COD)}2] (COD = 1,5-cyclooctadiene) lead to KCl elimination and the formation of the complexes, [Rh(η5-ArN)(ArN)CR}(COD)], in which the anionic ligand coordinates the rhodium centre in an unprecedented η5-cyclohexadienyl mode. The thermal conversions of these complexes to their N,N′-chelated isomers, [Rhκ2-N,N′-(ArN)2CR}(COD)], were carried out and the kinetics of these processes have been shown to be first order. The rates of the isomerisations are inversely proportional to the size of the amidinate or guanidinate backbone substituent. Analogies between the ligating properties of the bulky amidinates and guanidinates used in the study, and those of β-diketiminates are discussed.
    笨重的脒酸盐和酸盐 K[(ArN)2CR](R = But、NPri2 或 N(C6H11)2;Ar=2,6-二异丙基苯基)与[RhCl(η4-COD)}2](COD=1,5-环辛二烯)的反应导致 KCl 消解并形成[Rh(η5-ArN)(ArN)CR}(COD)]配合物,其中阴离子配体以前所未有的 η5-环己二烯模式配位中心。研究人员进行了这些配合物向其 N,N′-螯合异构体[Rhκ2-N,N′-(ArN)2CR}(COD)]的热转化,结果表明这些过程的动力学是一阶的。异构化的速率与脒基或基骨架取代基的大小成反比。研究中使用的大块脒基和基的连接特性与 β-二酮亚胺的连接特性进行了类比讨论。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫